Breaking Down AdaptHealth: 4 Analysts Share Their Views
Portfolio Pulse from Benzinga Insights
AdaptHealth (NASDAQ:AHCO) has been analyzed by 4 analysts in the last three months, showing a range of perspectives from bullish to somewhat bullish. The average 12-month price target has increased by 18.18% to $13.0. Analysts from Truist Securities, RBC Capital, and UBS have maintained or raised their ratings, reflecting positive sentiment.
May 15, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have shown a positive sentiment towards AdaptHealth (NASDAQ:AHCO) with an 18.18% increase in the average 12-month price target to $13.0. Analysts from Truist Securities, RBC Capital, and UBS have maintained or raised their ratings, indicating confidence in the company's future performance.
The increase in the average price target and the positive ratings from multiple analysts suggest a bullish outlook for AdaptHealth. This is likely to have a positive short-term impact on the stock price as investor sentiment improves.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100